Clinical Trials · NCT02475499
Incretin-based Drugs and Pancreatic Cancer
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Canadian Network for Observational Drug Effect Studies, CNODES
- Enrollment
- 886,172
- Start date
- Mar 2014
- Locations
- 1 site, Canada
- Primary endpoint
- Incident pancreatic cancer